BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30082842)

  • 21. Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.
    Zanjani LS; Madjd Z; Abolhasani M; Rasti A; Fodstad O; Andersson Y; Asgari M
    Biomark Med; 2018 Jan; 12(1):45-61. PubMed ID: 29243496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
    Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
    J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
    PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
    Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
    Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
    Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
    Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma.
    Silva CTX; Saddi VA; Silva KSFE; Sugita DM; Guillo LA
    Melanoma Res; 2021 Oct; 31(5):439-448. PubMed ID: 34433195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
    Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
    Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
    Siddiqui Z; Srivastava AN; Sankhwar SN; Dalela D; Singh V; Zaidi N; Fatima N; Bano I; Anjum S
    Br J Biomed Sci; 2020 Apr; 77(2):69-75. PubMed ID: 31718471
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
    Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
    Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma.
    Kim K; Ro JY; Kim S; Cho YM
    Hum Pathol; 2012 Dec; 43(12):2109-16. PubMed ID: 22944295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanog mediates tobacco smoke-induced enhancement of renal cancer stem cell properties.
    Zhang T; Sun H; Liu R; Cao W; Zhang T; Li E; Sun X; Wu W; Yu D; Zhong C
    Environ Toxicol; 2020 Nov; 35(11):1274-1283. PubMed ID: 32649042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
    BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
    Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma.
    Wang L; Zhang Y; Gao Y; Fan Y; Chen L; Liu K; Meng Q; Zhao C; Ma X
    Dis Markers; 2016; 2016():6870470. PubMed ID: 27092013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.